Noori H, Marsool M, Gohil K, Idrees M, Subash T, Alazzeh Z
Brain Behav. 2024; 14(8):e3644.
PMID: 39135307
PMC: 11319236.
DOI: 10.1002/brb3.3644.
Mangioris G, Halfdanarson T, Lennon V, Chang B, Dubey D, Dyck P
Eur J Neurol. 2024; 31(6):e16273.
PMID: 38466015
PMC: 11235830.
DOI: 10.1111/ene.16273.
Srichawla B, Doshi K, Cheraghi S, Sivakumar S
Neurol Sci. 2023; 44(11):3809-3817.
PMID: 37453952
DOI: 10.1007/s10072-023-06952-0.
Fang W, Tang J, Lin B, Lai Q, Cai M, Liu Z
CNS Neurosci Ther. 2022; 29(2):749-751.
PMID: 36525471
PMC: 9873508.
DOI: 10.1111/cns.14042.
Cacciaguerra L, Sechi E, Rocca M, Filippi M, Pittock S, Flanagan E
Front Neurol. 2022; 13:993645.
PMID: 36330423
PMC: 9623025.
DOI: 10.3389/fneur.2022.993645.
Paraneoplastic Neuromyelitis Optica Spectrum Disorder Related to Glucose-regulated Protein 78 (GRP78) Autoantibodies in a Patient with Lynch Syndrome-associated Colorectal Cancer.
Minomo S, Ichijo M, Shimizu F, Sato R, Kanda T, Takai Y
Intern Med. 2022; 62(11):1653-1657.
PMID: 36288992
PMC: 10292989.
DOI: 10.2169/internalmedicine.9783-22.
Investigating paraneoplastic aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder through a data-driven approach.
Dinoto A, Borin G, Campana G, Carta S, Ferrari S, Mariotto S
Eur J Neurol. 2022; 29(11):3466-3472.
PMID: 35767391
PMC: 9796285.
DOI: 10.1111/ene.15479.
Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case Report.
Maiorca C, Moret F, Martines V, Tramontano D, Papassifachis M, Bini S
Front Med (Lausanne). 2022; 8:743798.
PMID: 35111770
PMC: 8801522.
DOI: 10.3389/fmed.2021.743798.
AQP4-IgG positive paraneoplastic NMOSD: A case report and review.
Ding M, Lang Y, Cui L
Brain Behav. 2021; 11(10):e2282.
PMID: 34520629
PMC: 8553315.
DOI: 10.1002/brb3.2282.
Ocular Paraneoplastic Syndromes.
Przezdziecka-Dolyk J, Brzecka A, Ejma M, Misiuk-Hojlo M, Solis L, Herrera A
Biomedicines. 2020; 8(11).
PMID: 33182708
PMC: 7698240.
DOI: 10.3390/biomedicines8110490.
Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer.
Yuan J, Jia Z, Qin W, Hu W
Clin Interv Aging. 2019; 14:1039-1044.
PMID: 31239653
PMC: 6559253.
DOI: 10.2147/CIA.S202102.
Neuromyelitis optica spectrum disorder and adenocarcinoma of ovary: a novel association.
Sachdeva J, Bansal R, Takkar A, Singh R
BMJ Case Rep. 2019; 12(4).
PMID: 31023729
PMC: 6506012.
DOI: 10.1136/bcr-2018-227435.
Neuromyelitis optica spectrum disorder coincident with renal clear cell carcinoma: A case report.
Jin H, Hao H, Nan D, Luo J, Wang L, Gao F
Medicine (Baltimore). 2019; 98(6):e14229.
PMID: 30732138
PMC: 6380749.
DOI: 10.1097/MD.0000000000014229.
Paraneoplastic Neuromyelitis Optica Associated with Lung Adenocarcinoma in a Young Woman.
Baik K, Kim S, Shin H
J Clin Neurol. 2018; 14(2):246-247.
PMID: 29629530
PMC: 5897211.
DOI: 10.3988/jcn.2018.14.2.246.
Pattern Recognition of the Multiple Sclerosis Syndrome.
Zabad R, Stewart R, Healey K
Brain Sci. 2017; 7(10).
PMID: 29064441
PMC: 5664065.
DOI: 10.3390/brainsci7100138.
Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.
Sepulveda M, Sola-Valls N, Escudero D, Rojc B, Baron M, Hernandez-Echebarria L
Mult Scler. 2017; 24(13):1753-1759.
PMID: 28920766
PMC: 5832634.
DOI: 10.1177/1352458517731914.
Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.
Berger B, Hottenrott T, Rauer S, Stich O
BMC Neurol. 2017; 17(1):5.
PMID: 28068933
PMC: 5223419.
DOI: 10.1186/s12883-016-0779-9.
Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
Rosales D, Kister I
Curr Allergy Asthma Rep. 2016; 16(6):42.
PMID: 27167974
DOI: 10.1007/s11882-016-0619-4.
Aquaporin-4 autoimmunity.
Zekeridou A, Lennon V
Neurol Neuroimmunol Neuroinflamm. 2015; 2(4):e110.
PMID: 26185772
PMC: 4442096.
DOI: 10.1212/NXI.0000000000000110.